相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure et al.
CLINICAL CANCER RESEARCH (2021)
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Kjetil Boye et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models
Montserrat Puigdelloses et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes
John A. Ligon et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu et al.
NATURE COMMUNICATIONS (2020)
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma
Yan Zhou et al.
NATURE COMMUNICATIONS (2020)
Oncolytic viruses: overcoming translational challenges
Jordi Martinez-Quintanilla et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
Marie-Francoise Heymann et al.
CELLULAR IMMUNOLOGY (2019)
CD163 Is Required for Protumoral Activation o Macrophages in Human and Murine Sarcoma
Daisuke Shiraishi et al.
CANCER RESEARCH (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas A Phase 2 Clinical Trial
Maud Toulmonde et al.
JAMA ONCOLOGY (2018)
Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
Sheng-Yen Lin et al.
AUTOPHAGY (2018)
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
Cariad Chester et al.
BLOOD (2018)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Juliane Gust et al.
CANCER DISCOVERY (2017)
The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Naiara Martinez-Velez et al.
CLINICAL CANCER RESEARCH (2016)
Agonists of Co-stimulation in Cancer Immunotherapy Directed Against CD137, 0X40, GITR, CD27, CD28, and ICOS
Miguel F. Sanmamed et al.
SEMINARS IN ONCOLOGY (2015)
The Oncolytic Adenovirus Δ24-RGD in Combination With Cisplatin Exerts a Potent Anti-Osteosarcoma Activity
Naiara Martinez-Velez et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
4-1BB Ligand Activates Bystander Dendritic Cells To Enhance Immunization in Trans
Douglas C. Macdonald et al.
JOURNAL OF IMMUNOLOGY (2014)
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
Hong Jiang et al.
PLOS ONE (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
Emilie P. Buddingh et al.
CLINICAL CANCER RESEARCH (2011)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
J. Thorburn et al.
CELL DEATH AND DIFFERENTIATION (2009)
Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter
Marta M. Alonso et al.
CANCER RESEARCH (2007)
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Alexander J. Chou et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Role of 4-1BB:4-1BB ligand in cancer immunotherapy
ATC Cheuk et al.
CANCER GENE THERAPY (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Inhibition of lung metastasis of osteosarcoma cell line POS-1 transplanted into mice by thigh ligation
A Kamijo et al.
CANCER LETTERS (2002)
分享论文
